Psychiatrists can now prescribe a cognitive behavioral therapy app that takes basic therapy one step further with digital adaptions to improve insomnia, sleep apnea, and mood.

Higher antipsychotic doses are more likely to elevate prolactin. Enter: Vitamin B6.

If approved, this alternative to IV brexanolone will be a more practical option for treating PPD.

The straight facts on Loreev, a new extended-release formulation of lorazepam (Ativan).

After reading these articles, you should be able to…

By successfully completing the test you will be awarded a certificate for 1 CME credit.

Dr. Miller discusses new options for negative symptoms, how to improve the therapeutic alliance, and what to do when clozapine doesn’t work in schizophrenia.

Off-label gabapentin (Neurontin) got a bad rep when it missed the mark in bipolar disorder, but there may be something worth salvaging in this drug. Here, we weigh its pros and cons for anxiety, substance use disorders, sleep, pain, and hot flashes, and compare it to its underutilized cousin, pregabalin (Lyrica).

MDMA is being repurposed as part of drug-assisted psychotherapy for PTSD, and this trial will help determine whether it gains FDA approval for that use.

In December 2021, the FDA approved lumateperone (Caplyta) for bipolar I and II depression, and here we report on one of the trials that led to that approval.